Mycosis fungoides laboratory findings: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| (28 intermediate revisions by 5 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{ | {{Mycosis fungoides}} | ||
{{CMG}}; {{AE}} {{ | {{CMG}}; {{AE}} {{S.G.}} | ||
==Overview== | |||
Laboratory tests for cutaneous T cell lymphoma include [[complete blood count]] (CBC), blood chemistry studies, [[flow cytometry]], [[immunohistochemistry]], and [[immunophenotyping]]. | |||
== | ==Laboratory Tests== | ||
Laboratory tests for | [[Medical laboratory|Laboratory]] tests for mycosis fungoides include:<ref name="VuralAkay2018">{{cite journal|last1=Vural|first1=Seçil|last2=Akay|first2=Bengü Nisa|last3=Botsali|first3=Ayşenur|last4=Atilla|first4=Erden|last5=Parlak|first5=Nehir|last6=Okcu Heper|first6=Aylin|last7=Şanlı|first7=Hatice|title=Transformation of Mycosis Fungoides/Sezary Syndrome: Clinical Characteristics and Prognosis|journal=Turkish Journal of Hematology|volume=35|issue=1|year=2018|pages=35–41|issn=13007777|doi=10.4274/tjh.2016.0502}}</ref> | ||
* [[Complete blood count]] ([[Complete blood count|CBC]]) | |||
* Peripheral [[blood]] [[Smear test|smear]] | |||
* [[ | :* Atypical [[T cell|T-cells]] (Sezary [[Cell (biology)|cells]]) | ||
* | :* [[Allogeneic]] [[hematopoietic stem cell transplantation]] (allo-[[Hematopoietic stem cell transplantation|HSCT]]) demonstrated progressive [[disease]] had undergone. | ||
* [[Blood]] [[chemistry]] studies | |||
:* High level [[lactate dehydrogenase]] ([[LDH]])in andvanced [[disease]] stage [[Patient|patients]] | |||
* [[Biopsy]] of [[skin]] ( multiple [[Biopsy|biopsies]]) | |||
**A rare evaluated finding observed [[Mononucleosis|mono]] [[nuclear]] [[Cell (biology)|cells]] aggrigation by cerebriform [[nuclei]] in the [[Epidermis (skin)|epidermis]] surrounding [[Langerhans cell|langerhans cells]]. | |||
**Atypical [[Lymphocyte|lymphocytes]] observed in the [[Epidermis (skin)|epidermis]] or [[Superficial anatomy|superficial]] [[Dermis|dermi]]<nowiki/>[[Dermis|s]]. | |||
*[[Lymph node]] [[Biopsy|biopsies]] is recommended. | |||
* complete [[Metabolic control analysis|metabolic]] [[Panel data|panel]] | |||
* [[Flow cytometry]] | * [[Flow cytometry]] | ||
* [[Immunohistochemistry]] | * [[Immunohistochemistry]] | ||
* [[Immunophenotyping]]: Beta F1+, [[CD2]]-/+, [[CD3]]+, [[CD3]]- ([[CD4]]-positive variant), [[CD4]]+ ([[CD4]]-positive variant), [[CD4]]-, [[CD5]]-, [[CD7]]+/-, [[CD8]]+, [[CD8]]- ([[CD4]]-positive variant), Granzyme B+, | * [[Immunophenotyping]]: Beta F1+, [[CD2]]-/+, [[CD3]]+, [[CD3]]- ([[CD4]]-positive variant), [[CD4]]+ ([[CD4]]-positive variant), [[CD4]]-, [[CD5]]-, [[CD7]]+/-, [[CD8]]+, [[CD8]]- ([[CD4]]-positive variant), [[Granzyme B|Granzyme B+]], and [[perforin]]+ | ||
* Loss of CD26 and [[CD7]] [[expression]] | |||
* [[Polymerase chain reaction|PCR]] | |||
* [[Southern blot]] | |||
==References== | ==References== | ||
{{Reflist| | {{Reflist|1}} | ||
[[Category:Disease]] | [[Category:Disease]] | ||
| Line 22: | Line 34: | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Hematology]] | |||
[[Category:Immunology]] | |||
Latest revision as of 07:10, 11 February 2019
|
Mycosis fungoides Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Mycosis fungoides laboratory findings On the Web |
|
American Roentgen Ray Society Images of Mycosis fungoides laboratory findings |
|
Risk calculators and risk factors for Mycosis fungoides laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sogand Goudarzi, MD [2]
Overview
Laboratory tests for cutaneous T cell lymphoma include complete blood count (CBC), blood chemistry studies, flow cytometry, immunohistochemistry, and immunophenotyping.
Laboratory Tests
Laboratory tests for mycosis fungoides include:[1]
- Complete blood count (CBC)
- Peripheral blood smear
- Atypical T-cells (Sezary cells)
- Allogeneic hematopoietic stem cell transplantation (allo-HSCT) demonstrated progressive disease had undergone.
- High level lactate dehydrogenase (LDH)in andvanced disease stage patients
- Biopsy of skin ( multiple biopsies)
- A rare evaluated finding observed mono nuclear cells aggrigation by cerebriform nuclei in the epidermis surrounding langerhans cells.
- Atypical lymphocytes observed in the epidermis or superficial dermis.
- Lymph node biopsies is recommended.
- complete metabolic panel
- Flow cytometry
- Immunohistochemistry
- Immunophenotyping: Beta F1+, CD2-/+, CD3+, CD3- (CD4-positive variant), CD4+ (CD4-positive variant), CD4-, CD5-, CD7+/-, CD8+, CD8- (CD4-positive variant), Granzyme B+, and perforin+
- Loss of CD26 and CD7 expression
- PCR
- Southern blot
References
- ↑ Vural, Seçil; Akay, Bengü Nisa; Botsali, Ayşenur; Atilla, Erden; Parlak, Nehir; Okcu Heper, Aylin; Şanlı, Hatice (2018). "Transformation of Mycosis Fungoides/Sezary Syndrome: Clinical Characteristics and Prognosis". Turkish Journal of Hematology. 35 (1): 35–41. doi:10.4274/tjh.2016.0502. ISSN 1300-7777.